数理医药学杂志
數理醫藥學雜誌
수리의약학잡지
Journal of Mathematical Medicine
2015年
10期
1521-1522
,共2页
慢性乙型肝炎%肝硬化%联合治疗%前列地尔%替比夫定
慢性乙型肝炎%肝硬化%聯閤治療%前列地爾%替比伕定
만성을형간염%간경화%연합치료%전렬지이%체비부정
chronic hepatitis B%liver cirrhosis%combined therapy%alprostadil%telbivudine
目的：：探讨慢性乙型肝炎肝硬化患者的临床治疗过程中，应用替比夫定与前列地尔联合治疗的临床效果。方法：选取某院2013年4月~2014年6月收治的60例慢性乙型肝炎肝硬化患者作为研究对象，随机分为观察组与对照组各30例。观察组应用替比夫定与前列地尔联合治疗；对照组仅给予替比夫定治疗。结果：对两组患者的肝功能变化情况，观察组肝功能改善情况明显高于对照组(P <0.05)，有统计学意义。结论：慢性乙型肝炎肝硬化患者的临床治疗过程中，应用替比夫定与前列地尔联合治疗，具有较好效果，值得临床推广。
目的：：探討慢性乙型肝炎肝硬化患者的臨床治療過程中，應用替比伕定與前列地爾聯閤治療的臨床效果。方法：選取某院2013年4月~2014年6月收治的60例慢性乙型肝炎肝硬化患者作為研究對象，隨機分為觀察組與對照組各30例。觀察組應用替比伕定與前列地爾聯閤治療；對照組僅給予替比伕定治療。結果：對兩組患者的肝功能變化情況，觀察組肝功能改善情況明顯高于對照組(P <0.05)，有統計學意義。結論：慢性乙型肝炎肝硬化患者的臨床治療過程中，應用替比伕定與前列地爾聯閤治療，具有較好效果，值得臨床推廣。
목적：：탐토만성을형간염간경화환자적림상치료과정중，응용체비부정여전렬지이연합치료적림상효과。방법：선취모원2013년4월~2014년6월수치적60례만성을형간염간경화환자작위연구대상，수궤분위관찰조여대조조각30례。관찰조응용체비부정여전렬지이연합치료；대조조부급여체비부정치료。결과：대량조환자적간공능변화정황，관찰조간공능개선정황명현고우대조조(P <0.05)，유통계학의의。결론：만성을형간염간경화환자적림상치료과정중，응용체비부정여전렬지이연합치료，구유교호효과，치득림상추엄。
Objective:To investigate the clinical application effect of telbivudine plus Alprostadil on chro-nic hepatitis B cirrhosis.Methods:60 patients with chronic hepatitis B cirrhosis received in our hospital dur-ing the period from April 2013 to June 2014 were selected as the research object and were randomly divided into observation group and control group ,30 cases for each group.The observation group were treated with telbivudine plus alprostadil ;the control group only received telbivudine .Results:To compare the changes of liver function of the patients in the two groups,in the observation group,the improvement in liver function was significantly superior to that in control group (P <0.05),and the difference was statistically significant. Conclusion:During the clinical treatment course of chronic hepatitis B cirrhosis,it is effective to apply telbivu-dine plus alprostadil ,and it is worthy of clinical promotion.
